반응형
| 구분 | 보고서(영문) |
| 제약/바이오/ 임상시험 (7건) |
Are Clinical Trial Sites Unfairly Bearing the Brunt of Trial Failures? |
| The FDA Awarded a Record Number of Review Designations to mRNA Vaccines in 2023 | |
| Capvaxive Will Enhance Protection Against Pneumococcal Disease in Older Adults | |
| FDA Approval of Verona’s Ohtuvayre to Transform the US COPD Market for Exacerbators | |
| North America Leads in Psychedelic Therapy Trials | |
| CAR-T Landscape Set to Increase for 2024 | |
| FDA Approves Eli Lilly’s Kisunla (Donanemab) for Early Alzheimer’s Disease | |
| 컨퍼런스/ 심포지엄/ 학회/기타 (14건) |
May Quarterly Contract Manufacturing Mergers, Acquisitions, and Financing – Q2 2024 |
| Blockbuster Deals Are Shaping Key Player CMOs Despite 31% Drop in M&A | |
| Contract Manufacturing: Opportunities and Threats – May 2024 | |
| Gay and Bisexual Men Have a Significantly Higher Risk of Anxiety and Depression | |
| Contract Service Agreements – May 2024 | |
| CAR T-Cells in Lupus: Promising Results at EULAR 2024 and Emergence of China | |
| Heatwave Increases Risk of Serious Cardiovascular Health Problems | |
| UK’s Antibiotic Subscription Funding Model—a Route to Market Sustainability? | |
| EAN 2024: Anti-CGRPs More Effective Than Onabotulinumtoxin A in Chronic Migraine Prevention in Real-World | |
| EAN 2024: Additional Analyses of Pridopidine Healey ALS Platform Trial Encouraging for Phase III Plans | |
| EAN 2024: VNS and cenobamate – a new therapeutic alliance for drug-resistant epilepsy? | |
| EAN 2024: Treatment Cessation and Re-initiation Can Reduce Benefits of Ajovy | |
| EAN 2024: Benefits of Early Migraine Treatment Clear, but Implementation Remains Challenging | |
| EAN 2024: Sublingual Apomorphine Better Tolerated by Dopamine Agonist Users | |
| 질환별 (11건) |
Chronic Kidney Disease: Seven -Market Drug Forecast and Market Analysis |
| Osteoporosis: Seven-Market Drug Forecast and Market Analysis | |
| Impact and Implications of the $35 Monthly Price Cap on Asthma Inhalers | |
| Prurigo Nodularis: Competitive Landscape | |
| Female Infertility: Seven -Market Drug Forecast and Market Analysis | |
| Soft Tissue Sarcoma: Competitive Landscape | |
| Female Infertility: 68-Market Drug Analysis and Sales Forecast | |
| Tay-Sachs Disease: Competitive Landscape | |
| Presbyopia: Competitive Landscape | |
| Primary Sclerosing Cholangitis: Competitive Landscape | |
| Pharmaceutical Companies Are Shaping a Competitive Pipeline Landscape for Bronchiectasis |
반응형
'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글
| 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 8.30. (금) (0) | 2024.09.15 |
|---|---|
| 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 8.14. (수) (0) | 2024.09.15 |
| 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 6.20. (목) (0) | 2024.09.15 |
| 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 6.3. (수) (0) | 2024.09.15 |
| 해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 5.24. (금) (0) | 2024.09.15 |